Cipla spurted 8.24% to Rs 427.40 on bargain hunting after a recent steep slide.
Shares of Cipla slumped 11.80% in the past five trading sessions to settle at Rs 394.85 yesterday, 12 March 2020 from its close of Rs 447.70 on 4 March 2020. The stock hit a 52-week low at Rs 356.75 in early trade today.
Meanwhile, Cipla's board in a meeting on Thursday, 12 March 2020, approved an interim dividend of Rs 3 per equity share and a one-time special dividend of Re 1 per share for the FY 2019-20. The record date is fixed on 20 March 2020.
On a consolidated basis, Cipla's net profit rose 5.7% to Rs 351.03 crore in Q3 December 2019 as against Rs 332.20 crore reported in Q3 December 2018. Net sales advanced 8.4% year-on-year (YoY) to Rs 4,234.55 crore in Q3 FY20.
Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
